Published: Jan. 27, 2021, 8 a.m.
Answer all your burning questions (and your patients\u2019 burning questions) about the different COVID-19 vaccines currently authorized in the US. Infectious diseases / HIV expert, Dr Monica Gandhi @MonicaGandhi9 (UCSF) joins us to cover: the Pfizer-BioNTech and Moderna novel mRNA vaccine mechanisms, trial data, and practicalities of who should receive them.\xa0 We discuss data around the Oxford-AstraZeneca adenovirus vaccine, which is authorized in the UK and India, and may be available in the US later this year.\xa0 Feel confident recommending COVID-19 vaccines to your patients!\n
\n\n\nEpisodes | Subscribe | Spotify | Swag! | Top Picks | Mailing List | thecurbsiders@gmail.com | Free CME!\n\n\n
\n
\nCredits
\n
\n\n\n
\n- Written and Produced by: Molly Heublein, MD
\n- Cover Art: Chris Chiu, MD, FACP, FAAP
\n- Infographic: Tima Karginov
\n- Hosts: Chris Chiu, MD, FACP, FAAP; Molly Heublein, MD; Paul Williams, MD, FACP
\n- Editor: Emi Okamoto MD (written materials); Clair Morgan of Nodderly.com (audio)
\n- Guest: Monica Gandhi, MD, MPH
\n
\n
\n\n
\n\n\n
\nSponsor: Panacea Financial\xa0
\nThis episode is supported by Panacea Financial, digital banking built for doctors, by doctors. At Panacea Financial you can have your own free personal banker and a support team that works around the clock- just like you do. Open your free checking account today at
panaceafinancial.com\n\n
\n\n
Panacea Financial, a Division of Sonabank, Member FDIC\n
\n\n\n
\n
\nSponsor: VCU Health CE
\nThe Curbsiders are partnering with
VCU Health Continuing Education to offer FREE continuing education credits for physicians and other healthcare professionals. Visit
curbsiders.vcuhealth.org.\n\n\n
\n
\n
\nTime Stamps
\n\n\n\n
\n- Intro, disclaimer, guest bio - 00:00
\n- \n\xa0Guest one-liner, book recommendation - 3:40
\n- Authorized vaccines in the US - 8:30
\n- AstraZeneca vaccine mechanism- 9:26
\n- mRNA vaccine mechanism - 10:30
\n- Vaccine distribution issues (cold chain) - 16:05
\n- mRNA safety - 18:24
\n- mRNA vaccine efficacy/data from phase 3 trials - 19:40
\n- How did we get this so quickly - 23:40
\n- Vaccine impact on asymptomatic infection - 26:18
\n- AstraZeneca trials - 28:20
\n- Pregnancy - 35:10
\n- Anaphylaxis - 37:10
\n- Prior COVID-19 infection - 39:07
\n- Side effects - 42:05
\n- Pediatric patients - 45:12
\n- Phases of role outs in the US -46:50
\n- Herd immunity - 48:16
\n- Thoughts of how to make this happen - 52:45
\n- Preexisting conditions - 53:40
\n- How long will immunity last - 57:15
\n- Mutant strains - 58:25
\n- Future of mRNA vaccines - 1:00:30
\n- Take home points and Outro - 1:02:12
\n